NIVF

+ Watchlist + Portfolio

NewGenIvf Group Limited

Regulated industryTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $0.10
52-Week Range: $0.06 – $1,539.00
Market Cap: $359.86K
P/E (TTM): 0.00
EPS (TTM): 328.32
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 0.00
PEG Ratio: —
Return on Equity: 79.40%
Return on Assets: -36.94%
Gross Margin: 20.22%
Operating Margin: -349.13%
Profit Margin: 209.03%
Current Ratio: 3.12
Debt/Equity: 0.19
Total Debt: $4.87M
Free Cash Flow: $-10.46M
Revenue Growth: 11.90%
Earnings Growth: —
Enterprise Value: $3.28M

NIVF Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$5.94M	$5.14M	$5.43M	$4.73M
Cost of Revenue	$4.41M	$3.45M	$3.61M	$3.77M
Gross Profit	$1.54M	$1.68M	$1.83M	$955.85K
Selling, General & Admin	$1.14M	$1.64M	$2.99M	$11.68M
Operating Expenses	$1.14M	$1.64M	$2.99M	$11.68M
Operating Income	$398.70K	$42.24K	-$1.16M	-$10.73M
EBITDA	$725.69K	$384.31K	$24.11K	$10.84M
Pretax Income	$343.99K	$108.42K	-$960.81K	$9.73M
Income Tax	$208.14K	$0.00	-$486.71K	$0.00
Net Income	$458.67K	$130.19K	-$524.64K	$9.88M
Diluted EPS	8190.48	2324.88	-4163.83	109.44
Diluted Shares	56	56	126	90278

NIVF Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$27.56K	$54.10K	$457.74K	$758.62K
Receivables	$2.32M	$519.55K	$1.36M	$1.07M
Inventory	$46.91K	$126.26K	$80.81K	$335.36K
Current Assets	$2.40M	$2.46M	$3.17M	$7.38M
Total Assets	$2.90M	$4.49M	$3.58M	$32.72M
Current Liabilities	$2.56M	$1.12M	$2.72M	$2.37M
Long-Term Debt	—	—	$2.33M	$4.10M
Total Debt	$452.04K	$332.55K	$3.03M	$4.86M
Total Liabilities	$2.80M	$1.24M	$5.06M	$6.74M
Retained Earnings	-$591.54K	-$461.35K	-$985.99K	$8.89M
Shareholders' Equity	$563.11K	$3.74M	-$1.05M	$26.63M
Working Capital	-$157.03K	$1.34M	$452.39K	$5.02M
Net Debt	—	—	$2.45M	$3.59M

NIVF Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$1.71M	-$1.77M	-$8.26M	-$10.93M
Capital Expenditure	-$94.45K	-$69.85K	-$53.05K	-$5.75M
Free Cash Flow	$1.62M	-$1.84M	-$8.32M	-$16.68M
Depreciation & Amortisation	$303.94K	$229.71K	$206.26K	$499.50K
Investing Cash Flow	-$94.45K	-$69.85K	-$53.05K	-$7.56M
Financing Cash Flow	-$1.63M	$1.88M	$8.68M	$18.99M
Dividends Paid	$0.00	$0.00	$0.00	$0.00
Net Change in Cash	-$17.33K	$45.51K	$358.67K	$506.93K

NIVF Income statement, quarterly periods, in USD
USD	Q4 2024	Q3 2025	Q4 2025
Revenue	$1.27M	$1.28M	$1.42M
Cost of Revenue	$734.48K	$1.16M	$900.53K
Gross Profit	$539.13K	$118.02K	$524.02K
Selling, General & Admin	$1.63M	$2.63M	$5.50M
Operating Expenses	$1.63M	$2.63M	$5.50M
Operating Income	-$1.09M	-$2.51M	-$4.97M
EBITDA	-$121.58K	$16.80M	-$7.27M
Pretax Income	-$542.68K	$16.75M	-$7.72M
Income Tax	-$486.71K	$0.00	$0.00
Net Income	-$108.24K	$16.82M	-$7.67M

Market Snapshot

About

NewGenIvf Group Limited operates a network of fertility clinics across Southeast Asia providing in vitro fertilization (IVF) and related reproductive health services. The company addresses the growing demand for assisted reproductive technology in the region. NewGenIvf combines medical expertise with accessible fertility care.